"Oncology Associates at Mercy Medical Center provides high-quality hematology and oncology care for cancer patients close to home."

During the past decade, Oncology Associates at Mercy Medical Center conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 133 clinical trials were completed, i.e. on average, 184.7% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 39 clinical trials were completed. i.e. 130% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncology Associates at Mercy Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 96 trials, followed by "National Cancer Institute (NCI)" with 80 trials sponsored, "SWOG Cancer Research Network" with 22 trials sponsored, "Eastern Cooperative Oncology Group" with 15 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Associates at Mercy Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 170 trials as a collaborator, "NCIC Clinical Trials Group" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 14 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator and "SWOG Cancer Research Network" with 11 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Oncology Associates at Mercy Medical Center" are "Breast Cancer" (36 trials), "Lung Cancer" (19 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials), "Colorectal Cancer" (13 trials) and "Pain" (8 trials). Many other conditions were trialed in "Oncology Associates at Mercy Medical Center" in a lesser frequency.

Most popular intervention types in "Oncology Associates at Mercy Medical Center" are "Drug" (218 trials), "Other" (132 trials), "Biological" (95 trials), "Procedure" (44 trials) and "Radiation" (33 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (47 trials), "Quality-of-Life Assessment" (42 trials), "placebo" (34 trials), "Paclitaxel" (22 trials) and "Questionnaire Administration" (22 trials). Other intervention names were less common.

The vast majority of trials in "Oncology Associates at Mercy Medical Center" are 216 trials for "All" genders, 43 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Oncology Associates at Mercy Medical Center". undefined are not yet recruiting, 26 are recruiting, 72 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 143 completed trials in Oncology Associates at Mercy Medical Center, 4 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Oncology Associates at Mercy Medical Center, 10 "Phase 1" clinical trials were conducted, 102 "Phase 2" clinical trials and 142 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".